The effect on plasma insulin of elevating plasma glucose levels was studied in exteriorized sheep fetuses of 68 to 142 days conceptual age and in 2 lambs, 1 and 7 days old. Fetuses of less than 110 days showed, at most, only a very small and delayed rise in plasma insulin following an injection of glucose (1.67–3.45 g/kg body weight) into the umbilical vein. In 5 out of 6 fetuses of 110 days and older intravenous glucose (0.54–1.38 g/kg) was followed by a marked but delayed rise in plasma insulin reaching a peak 25–100 min after glucose administration. In the lambs intravenous glucose (1 g/kg) gave an immediate response in plasma insulin. Intraduodenal glucose was also seen to give a marked rise in plasma insulin in a 123 day fetus and 2 lambs. Intravenous fructose (0.65 and 0.55 g/kg) to two older fetuses caused no rise in plasma insulin although glucose given subsequently evoked a marked response. The onset of appearance of a marked response to glucose in the fetus was preceded by a proliferation of secondary islets in the pancreas. The changes in plasma insulin in the exteriorized fetuses and in 2 isolated fetuses suggest that the placenta must be relatively impermeable to insulin, fetal insulin must largely be derived from the fetal pancreas and fetal tissues must take up insulin.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.